Beck Bode LLC purchased a new stake in The Allstate Corporation (NYSE:ALL – Free Report) during the second quarter, according to its most recent filing with the SEC. The firm purchased 3,771 shares of the insurance provider’s stock, valued at approximately $759,000.
Several other hedge funds and other institutional investors have also bought and sold shares of ALL. Arlington Trust Co LLC increased its stake in Allstate by 261.8% in the second quarter. Arlington Trust Co LLC now owns 123 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 89 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its holdings in shares of Allstate by 315.0% in the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 166 shares of the insurance provider’s stock valued at $33,000 after buying an additional 126 shares during the period. Hilltop National Bank bought a new stake in shares of Allstate in the 2nd quarter valued at $34,000. Chilton Capital Management LLC bought a new stake in shares of Allstate in the 2nd quarter valued at $38,000. Finally, Meeder Asset Management Inc. raised its stake in Allstate by 113.8% during the 1st quarter. Meeder Asset Management Inc. now owns 186 shares of the insurance provider’s stock worth $39,000 after buying an additional 99 shares during the period. Institutional investors own 76.47% of the company’s stock.
Allstate Stock Up 1.7%
Shares of Allstate stock opened at $207.28 on Wednesday. The firm has a market cap of $54.24 billion, a PE ratio of 9.75, a P/E/G ratio of 0.69 and a beta of 0.35. The business’s 50 day simple moving average is $201.95 and its 200 day simple moving average is $201.40. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.43 and a current ratio of 0.43. The Allstate Corporation has a 52-week low of $176.00 and a 52-week high of $215.70.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on ALL. Citigroup raised Allstate to a “hold” rating in a research note on Wednesday, August 13th. Jefferies Financial Group lifted their price objective on Allstate from $254.00 to $255.00 and gave the company a “buy” rating in a report on Monday, August 11th. Wolfe Research raised Allstate to a “strong-buy” rating in a research note on Tuesday, September 16th. Cantor Fitzgerald upgraded shares of Allstate to a “hold” rating in a report on Wednesday, August 13th. Finally, Keefe, Bruyette & Woods lifted their price target on shares of Allstate from $246.00 to $250.00 and gave the company an “outperform” rating in a research note on Tuesday. Two analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $237.13.
View Our Latest Research Report on Allstate
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Recommended Stories
- Five stocks we like better than Allstate
- Quiet Period Expirations Explained
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
- How to Read Stock Charts for Beginners
- Strategy Shares Plunge as Bitcoin Retreats—More Pain Ahead?
- Health Care Stocks Explained: Why You Might Want to Invest
- BigBear.ai Stock Is Range-Bound—Wall Street Isn’t Buying the Hype
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
